Microbiome-based therapeutics in clinical practice: how can we be better stewards

This talk explores the role of intestinal microbiome-based therapeutics in treating recurrent Clostridioides difficile infection (CDI) and the broader implications for clinical stewardship. Dr Susy Hota examines the practical and ethical challenges of faecal microbiota transplantation (FMT), highlighting risks, regulatory barriers, and the urgent need for oversight in the expanding field of microbiome-based therapies. The session outlines a path toward responsible, patient-centred implementation through models such as Centres of Excellence.